Results 81 to 90 of about 1,646,514 (244)

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Economic Openness, Disciplined Government and Ethnic Peace [PDF]

open access: yes
Many studies have examined the determinants of ethnic conflicts in multi-ethnic developing countries and report a myriad of contributory factors. It is natural to observe many correlates because ethnic wars tend to gain their own momentum and proceed for
Tilak Abeysinghe, Nava Ravi Kumaran
core  

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

open access: yesMolecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur   +11 more
wiley   +1 more source

Ethnic Factor as a Prerequisite of Ethnopolitical Conflict

open access: yesHistoria i Polityka, 2015
The actuality of this article lies in understanding the role of the ethnic factor in the ethnopolitical conflict. Especially, the article examines the peculiarities of the usage of the term “ethnicity”, approaches to understanding ethnicity in Ukrainian ...
Habriella Rodyk
doaj   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Death as a measure of duration of conflict [PDF]

open access: yes
This paper argues that number of deaths in a conflict can be a measure of duration and demonstrates that there are information gains to this approach.
Sacit Hadi Akdede, Ayla Ogus
core  

Ethnic Fractionalization, Ethnic Polarization, and Potential Conflict in Parent Districts of IKN

open access: yesJurnal Ilmu Sosial dan Humaniora
The purpose of this research is to determine the degree of ethnic fractionalization and polarization in the parent districts of the new Indonesian Capital of Nusantara (IKN), namely Kutai Kartanegara (Kukar) and North Penajam Paser (PPU) Districts, and ...
I Ketut Gunawan
doaj   +1 more source

Descriptive representation and political participation: exploring Croatia's non-dominant groups electoral turnout

open access: yesAnali Hrvatskog Politološkog Društva, 2019
The series of ethnic conflicts in the Western Balkans over the 1990s in- volved primarily the constituent nations of the Socialist Federal Republic of Yugoslavia: Serbs, Croats, Bosniaks, and later, Albanians and Macedonians.
Timofey Agarin, Petr Čermák
doaj   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy